High Growth Tech Stocks To Explore In January 2025

In This Article:

The United States market has shown robust performance with a 3.1% increase over the last week and a 24% rise over the past year, while earnings are projected to grow by 15% annually. In this favorable environment, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for innovation and scalability, aligning well with these positive market conditions.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Exelixis

62.05%

20.47%

★★★★★★

Super Micro Computer

24.13%

24.28%

★★★★★★

Ardelyx

21.46%

55.24%

★★★★★★

AVITA Medical

33.33%

51.81%

★★★★★★

Alkami Technology

21.99%

102.65%

★★★★★★

TG Therapeutics

29.87%

43.91%

★★★★★★

Bitdeer Technologies Group

50.44%

122.48%

★★★★★★

Clene

61.16%

59.11%

★★★★★★

Alnylam Pharmaceuticals

21.43%

56.40%

★★★★★★

Travere Therapeutics

30.02%

61.89%

★★★★★★

Click here to see the full list of 229 stocks from our US High Growth Tech and AI Stocks screener.

Let's dive into some prime choices out of from the screener.

Zai Lab

Simply Wall St Growth Rating: ★★★★★☆

Overview: Zai Lab Limited focuses on developing and commercializing therapies for oncology, autoimmune disorders, infectious diseases, and neuroscience, with a market capitalization of approximately $2.82 billion.

Operations: The company generates revenue primarily from its biotechnology segment, amounting to $355.75 million. Its focus on developing therapies across multiple medical fields supports its diversified business model.

Zai Lab's recent strides in drug development, particularly with the NMPA's acceptance of the New Drug Application for KarXT and FDA approval of COBENFY, underscore its potential in addressing significant unmet medical needs in schizophrenia treatment. These developments not only highlight Zai Lab's commitment to innovation but also position it favorably within the biotech sector, which is critical given the 30.5% annual revenue growth and forecasted shift to profitability within three years. Furthermore, Zai Lab's R&D investment aligns with its strategic focus on expanding its pipeline and enhancing drug efficacy and safety profiles, pivotal for long-term growth in a competitive industry landscape marked by rapid technological advancements and regulatory dynamics.

NasdaqGM:ZLAB Earnings and Revenue Growth as at Jan 2025
NasdaqGM:ZLAB Earnings and Revenue Growth as at Jan 2025

CarGurus

Simply Wall St Growth Rating: ★★★★★☆

Overview: CarGurus, Inc. operates an online automotive platform for buying and selling vehicles in the United States and internationally, with a market cap of approximately $3.92 billion.